electroCore (ECOR) Liabilities and Shareholders Equity (2017 - 2026)
electroCore (ECOR) posted Liabilities and Shareholders Equity of $17.1 million for Q2 2026, up 10.22% on a QoQ basis from $15.5 million in Q1 2026, and up 17.21% year-over-year from $14.6 million in Q2 2025.
Analysis
electroCore (ECOR) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends
electroCore has reported Liabilities and Shareholders Equity for 10 years, with the latest figure at $17.1 million in Q2 2026.
- On a quarterly basis, Liabilities and Shareholders Equity rose 17.21% year-over-year to $17.1 million in Q2 2026; TTM through Jun 2026 was $72.6 million, a 0.71% increase from a year earlier, with the FY2025 full-year figure at $18.7 million, down 8.81% from the prior year.
- Liabilities and Shareholders Equity was $17.1 million for Q2 2026 at electroCore, up from $15.5 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $37.2 million in Q1 2022, with the low at $13.9 million in Q1 2024.
- Average Liabilities and Shareholders Equity over 5 years is $20.8 million, with a median of $19.4 million recorded in 2023.
- The sharpest annual moves came in 2023 and 2024: Liabilities and Shareholders Equity slumped 57.52% in 2023, then soared 57.19% in 2024.
- Over 5 years, Liabilities and Shareholders Equity stood at $24.8 million in 2022, then plunged by 34.96% to $16.1 million in 2023, then grew by 27.13% to $20.5 million in 2024, then decreased by 8.81% to $18.7 million in 2025, then slipped by 8.59% to $17.1 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $17.1 million (Q2 2026), $15.5 million (Q1 2026), and $18.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 20.88 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 93.31 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 47.93 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 13.87 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 31.10 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 6.46 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 10.74 Bn |
| 10 | electroCore | 87.36 Mn | 77.32 Mn | 8.18 Mn | 17.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.06 Mn |
| Mar 31, 2026 | 15.48 Mn |
| Dec 31, 2025 | 18.67 Mn |
| Sep 30, 2025 | 21.41 Mn |
| Jun 30, 2025 | 14.56 Mn |
| Mar 31, 2025 | 16.04 Mn |
| Dec 31, 2024 | 20.47 Mn |
| Sep 30, 2024 | 21.05 Mn |
| Jun 30, 2024 | 22.36 Mn |
| Mar 31, 2024 | 13.89 Mn |
| Dec 31, 2023 | 16.10 Mn |
| Sep 30, 2023 | 20.11 Mn |
| Jun 30, 2023 | 14.22 Mn |
| Mar 31, 2023 | 18.30 Mn |
| Dec 31, 2022 | 24.76 Mn |
| Sep 30, 2022 | 29.49 Mn |
| Jun 30, 2022 | 33.48 Mn |
| Mar 31, 2022 | 37.18 Mn |
| Dec 31, 2021 | 42.83 Mn |
| Sep 30, 2021 | 47.57 Mn |